Computational models of the human neck have been developed to assess human response in impact scenarios; however, the assessment and validation of such models is often limited to a small number of experimental data sets despite being used to evaluate the efficacy of safety systems and potential for injury risk in motor vehicle collisions. In this study, a full neck model (NM) with active musculature was developed from previously validated motion segment models of the cervical spine. Tissue mechanical properties were implemented from experimental studies, and were not calibrated. The neck model was assessed with experimental studies at three levels of increasing complexity: ligamentous cervical spine in axial rotation, axial tension, frontal impact, and rear impact; postmortem human subject (PMHS) rear sled impact; and human volunteer frontal and lateral sled tests using an open-loop muscle control strategy. The neck model demonstrated good correlation with the experiments ranging from quasi-static to dynamic, assessed using kinematics, kinetics, and tissue-level response. The contributions of soft tissues, neck curvature, and muscle activation were associated with higher stiffness neck response, particularly for low severity frontal impact. Experiments presenting single-value data limited assessment of the model, while complete load history data and cross-correlation enabled improved evaluation of the model over the full loading history. Tissue-level metrics demonstrated higher variability and therefore lower correlation relative to gross kinematics, and also demonstrated a dependence on the local tissue geometry. Thus, it is critical to assess models at the gross kinematic and the tissue levels.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1115/1.4047866 | DOI Listing |
PLoS One
January 2025
Department of Otolaryngology Head and Neck Surgery, Yanbian University Affiliated Hospital, Yanji City, Yanbian Korean Autonomous Prefecture, Jilin Province, China.
Introduction: This meta-analysis examined the relationship between age-related hearing loss (ARHL) and depression in older adults, and further explored whether this relationship is moderated by age and gender.
Methods: We searched in 4 English databases: PubMed, Embase, Web of Science, and Cochrane Library. Ultimately, we identified 9 studies, involving 3 cohort studies and 6 cross-sectional studies.
PLoS One
January 2025
Department of ENT, Head and Neck Surgery, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, Tamil Nadu, India.
Aim: The perspectives and practices of healthcare professionals regarding ototoxicity in individuals with head and neck cancers are important for the implementation of ototoxicity monitoring. The current study aims to explore the oncologist's awareness and perspectives of ototoxicity and ototoxicity monitoring for individuals with head and neck cancer in a South-Indian district, using qualitative semi-structured interviews.
Method: The COnsolidated criteria for REporting Qualitative research (COREQ) Checklist was used to guide the method of the current qualitative study.
Cancer Immunol Immunother
January 2025
Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.
Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with a poor prognosis for survival. Risk factors include alcohol and tobacco abuse and infection with human papilloma virus (HPV). To enhance anti-tumor immune responses immunotherapeutic approaches are approved for recurrent metastatic disease but only approx.
View Article and Find Full Text PDFCancer Immunol Immunother
January 2025
Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Sichuan, 610041, Chengdu, China.
Background: Immune checkpoint inhibitors (ICIs) show optimal treatment effects on recurrent or metastatic nasopharyngeal carcinoma(R/M NPC). Nonetheless, whether metastatic sites impact ICIs efficacy remains unclear.
Methods: We performed a secondary analysis of R/M NPC patients treated with KL-A167, a programmed cell death-ligand 1(PD-L1) inhibitor, based on a multicenter, single-arm, phase II study from China between 2019 and 2021 years, which represents the first and most comprehensive analysis of the effectiveness of a PD-L1 inhibitor in patients who have been previously treated.
Cancer Immunol Immunother
January 2025
Department of Otorhinolaryngology-Head and Neck Surgery, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Nangang District, Harbin, 150001, Heilongjiang Province, China.
Background: Tumor-derived small extracellular vesicles (sEVs) play an essential role in reprogramming the tumor microenvironment. Metabolic reprogramming is an essential prerequisite for M2 polarization of tumor-associated macrophages (TAMs). This M2 phenotype is closely related to the immune dysfunction of CD8 T cells and subsequent tumor progression.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!